Abigail Caudle
Overview
Explore the profile of Abigail Caudle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
So A, Yi M, Simons J, Kuerer H, Caudle A, DeSnyder S, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):977-978.
PMID: 39562423
No abstract available.
2.
So A, Yi M, Simons J, Kuerer H, Caudle A, DeSnyder S, et al.
Ann Surg Oncol
. 2024 Oct;
32(2):922-930.
PMID: 39441324
Background: Trials evaluating omission of axillary dissection (ALND) in patients with cN0 breast cancer with positive sentinel lymph nodes (SLNs) have excluded neoadjuvant chemotherapy (NACT). It remains unclear whether the...
3.
Loveland-Jones C, Gaughan J, Caudle A, Murphy B, Samiian L, Byrum S, et al.
Eur J Surg Oncol
. 2024 Mar;
50(4):108245.
PMID: 38484493
Introduction: Targeted axillary dissection (TAD) is performed after neoadjuvant systemic therapy (NST) to decrease the rate of non-therapeutic axillary dissection (ALND) for patients with node-positive breast cancer. In order to...
4.
Ma C, Suman V, Sanati S, Vij K, Anurag M, Leitch A, et al.
JAMA Oncol
. 2024 Jan;
10(3):362-371.
PMID: 38236590
Importance: Adding fulvestrant to anastrozole (A+F) improved survival in postmenopausal women with advanced estrogen receptor (ER)-positive/ERBB2 (formerly HER2)-negative breast cancer. However, the combination has not been tested in early-stage disease....
5.
Diao K, Lei X, He W, Jagsi R, Giordano S, Smith G, et al.
Int J Radiat Oncol Biol Phys
. 2023 Sep;
118(3):626-631.
PMID: 37751792
Purpose: Breast and skin changes are underrecognized side effects of radiation therapy for breast cancer, which may have long-term implications for quality of life (QOL). Racial and ethnic disparities in...
6.
Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, et al.
Ann Surg Oncol
. 2023 Sep;
30(13):8327-8334.
PMID: 37670121
Background: Axillary lymph node (ALN) involvement is important for prognosis and guidance of multidisciplinary treatment of breast cancer patients. This study sought to identify preoperative clinicopathologic factors predictive of four...
7.
Diao K, Lei X, He W, Jagsi R, Giordano S, Smith G, et al.
Ann Surg
. 2023 May;
278(5):e1096-e1102.
PMID: 37232937
Objective: To compare long-term quality of life (QOL) outcomes in breast cancer survivors who received breast-conserving surgery with radiotherapy (BCS+RT) with those who received a mastectomy and reconstructive surgery (Mast+Recon)...
8.
Mehta S, Shenvi E, Blair S, Caudle A, Lowenstein L, Kelly K
Ann Surg Oncol
. 2022 Oct;
30(2):1120-1129.
PMID: 36222932
Background: Compliance with evidence-based treatment guidelines for gastric cancer across the United States is poor. This pilot study aimed to create and evaluate a change package for disseminating information on...
9.
Santiago L, Volk R, Checka C, Black D, Lee J, Colen J, et al.
J Surg Oncol
. 2021 Feb;
123(5):1206-1214.
PMID: 33577715
Purpose: To evaluate the acceptability and impact of 3D-printed breast models (3D-BMs) on treatment-related decisional conflict (DC) of breast cancer patients. Methods: Patients with breast cancer were accrued in a...
10.
Hwang E, Hyslop T, Hendrix L, Duong S, Bedrosian I, Price E, et al.
J Clin Oncol
. 2020 Mar;
38(12):1284-1292.
PMID: 32125937
Purpose: Primary endocrine therapy for ductal carcinoma in situ (DCIS) as a potential alternative to surgery has been understudied. This trial explored the feasibility of a short-term course of letrozole...